Evidence map›Paper›PMID 24886142›Full record

ArticleBMC microbiology2014

Immunobiotic Lactobacillus rhamnosus strains differentially modulate antiviral immune response in porcine intestinal epithelial and antigen presenting cells.

Julio Villena, Eriko Chiba, Maria Guadalupe Vizoso-Pinto, Yohsuke Tomosada, Takuya Takahashi, Takamasa Ishizuka, Hisashi Aso, Susana Salva, Susana Alvarez, Haruki Kitazawa

Abstract read
In one paragraph

Article in BMC microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Foods (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Enhancing Resistance toNutrients · 2025
    Article
  6. The therapeutic effects ofGut microbiome (Cambridge, England) · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. ImmunobioticInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Microorganisms · 2022
    Article
  15. The Mucus Binding Factor Is Not Necessary forInternational journal of molecular sciences · 2022
    Article
  16. Foods (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Foods (Basel, Switzerland) · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Julio VillenaFood and Feed Immunology Group, Laboratory of Animal Products Chemistry, Graduate School of Agricultural Science, Tohoku University, Sendai 981-8555, Japan. jcvillena@cerela.org.ar.
Eriko Chiba
Maria Guadalupe Vizoso-Pinto
Yohsuke Tomosada
Takuya Takahashi
Takamasa Ishizuka
Hisashi Aso
Susana Salva
Susana Alvarez
Haruki Kitazawa

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious findings suggested that Lactobacillus rhamnosus CRL1505 is able to increase resistance of children to intestinal viral infections. However, the intestinal cells, cytokines and receptors involved in the immunoregulatory effect of this probiotic strain have not been fully characterized.

resultsWe aimed to gain insight into the mechanisms involved in the immunomodulatory effect of the CRL1505 strain and therefore evaluated in vitro the crosstalk between L. rhamnosus CRL1505, porcine intestinal epithelial cells (IECs) and antigen presenting cells (APCs) from swine Peyer's patches in order to deepen our knowledge about the mechanisms, through which this strain may help preventing viral diarrhoea episodes. L. rhamnosus CRL1505 was able to induce IFN-α and -β in IECs and improve the production of type I IFNs in response to poly(I:C) challenge independently of Toll-like receptor (TLR)-2 or TLR9 signalling. In addition, the CRL1505 strain induced mRNA expression of IL-6 and TNF-α via TLR2 in IECs. Furthermore, the strain significantly increased surface molecules expression and cytokine production in intestinal APCs. The improved Th1 response induced by L. rhamnosus CRL1505 was triggered by TLR2 signalling and included augmented expression of MHC-II and co-stimulatory molecules and expression of IL-1β, IL-6, and IFN-γ in APCs. IL-10 was also significantly up-regulated by CRL1505 in APCs.

conclusionsIt was recently reviewed the emergence of TLR agonists as new ways to transform antiviral treatments by introducing panviral therapeutics with less adverse effects than IFN therapies. The use of L. rhamnosus CRL1505 as modulator of innate immunity and inductor of antiviral type I IFNs, IFN-γ, and regulatory IL-10 clearly offers the potential to overcome this challenge.

Indexed as

AnimalsAntigen-Presenting CellsCells, CulturedCytokinesEpithelial CellsGene Expression ProfilingHistocompatibility Antigens Class IIImmunologic FactorsLacticaseibacillus rhamnosusProbioticsReceptors, ImmunologicSwineCytokinesHistocompatibility Antigens Class IIImmunologic FactorsReceptors, Immunologic

Identifiers

PMID24886142
PMCPMC4035899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.